1
项与 EBV-CTL(Memorial Sloan-Kettering Cancer Center) 相关的临床试验A Phase II Study of the Therapeutic Effects Of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies
This is a Phase II trial to evaluate the efficacy and safety of human leukocyte antigen (HLA) partially-matched third-party allogeneic Epstein-Barr virus cytotoxic T lymphocytes (EBV-CTLs) for the treatment of EBV-induced lymphomas and EBV-associated malignancies.
100 项与 EBV-CTL(Memorial Sloan-Kettering Cancer Center) 相关的临床结果
100 项与 EBV-CTL(Memorial Sloan-Kettering Cancer Center) 相关的转化医学
100 项与 EBV-CTL(Memorial Sloan-Kettering Cancer Center) 相关的专利(医药)
100 项与 EBV-CTL(Memorial Sloan-Kettering Cancer Center) 相关的药物交易